EUVIMEDEUVIMED entdecken
Crossref

hCG trends after mifepristone and misoprostol for undesired pregnancy of unknown location

Sonya Bharadwa, Isabel Fulcher, Jennifer Fortin, Katherine D Pocius, Alisa B Goldberg

Contraception · 2024

DOI: 10.1016/j.contraception.2023.110343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contraception, 2024. Verfasst von Sonya Bharadwa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, MA, United States; Brigham & Women's Hospital, Department of Obstetrics, Gynecology, and Reproductive Biology, Boston…. Hauptthemen laut MEDLINE: Misoprostol, Pregnancy, Ectopic, Abortion, Spontaneous. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Society of Family Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To describe human chorionic gonadotropin (hCG) trends for patients with a pregnancy of unknown location (PUL) presenting for medication abortion by management strategy and outcome. STUDY DESIGN: This retrospective cohort study included patients presenting for medication abortion with a PUL at ≤42 days gestation managed with either (1) immediate mifepristone with serial hCG follow-up (same-day-start) or (2) hCG testing every 48 to 72 hours ± ultrasonography to confirm pregnancy location followed by treatment (delay-for-diagnosis). The primary outcome was percent hCG change over time between presentation and diagnosis, summarized using a multivariate regression model. RESULTS: Of the 55 same-day-start patients, none were treated for ectopic. The eight who eventually required suction curettage had median hCG percent changes (interquartile range) on days 3, 4, and 5 of +57% (-14 to 127; n = 2), +292% (226-353; n = 4), and +392% (n = 1), while the 41 successful medication abortions had declines of -64% (n = 1), -65% (-75 to -27; n = 17), and -77% (-85 to -68; n = 13). Of the 380 delay-for-diagnosis patients, the 30 ectopic pregnancies had day 3, 4, and 5 changes of +38% (-17 to 56; n = 14), +50% (17-71; n = 7), and +115% (87-177; n = 4). None of the ectopic pregnancies declined ≥50% by days 3 to 5. The hCG trend for ectopic pregnancies differed from successful medication abortions (p < 0.01), but not medication abortions with retained intrauterine pregnancies (p = 0.41). CONCLUSIONS: Serum hCG trends can help differentiate ectopic pregnancy from successful medication abortion, but cannot distinguish between ectopic and retained intrauterine pregnancy. IMPLICATIONS: Serial serum hCG testing is effective for confirming successful medication abortion and identifying patients requiring further follow-up among patients undergoing medication abortion for an undesired PUL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MisoprostolPregnancy, EctopicAbortion, SpontaneousPregnancyFemaleHumansMifepristoneRetrospective StudiesChorionic Gonadotropin

Stichwörter der Autor:innen

Ectopic pregnancyHCG trendsMedication abortionPregnancy of unknown location

Substanzen

MisoprostolMifepristoneChorionic Gonadotropin

Autor:innen und Institutionen

  • Harvard Medical School, Boston, MA, United States; Brigham & Women's Hospital, Department of Obstetrics, Gynecology, and Reproductive Biology, Boston, MA, United States. Electronic address: sonya.bharadwa@nm.org.
  • Harvard Medical School, Department of Global Health and Social Medicine, Boston, MA, United States; The Planned Parenthood League of Massachusetts, Boston, MA, United States.
  • The Planned Parenthood League of Massachusetts, Boston, MA, United States.
  • Harvard Medical School, Department of Global Health and Social Medicine, Boston, MA, United States; Massachusetts General Hospital, Boston, MA, United States.
  • Harvard Medical School, Boston, MA, United States; Brigham & Women's Hospital, Department of Obstetrics, Gynecology, and Reproductive Biology, Boston, MA, United States; The Planned Parenthood League of Massachusetts, B…

Förderung

  • Society of Family Planning

Zitieren

APA

Bharadwa, S., Fulcher, I., Fortin, J., Pocius, K. D., & Goldberg, A. B. (2024). hCG trends after mifepristone and misoprostol for undesired pregnancy of unknown location. Contraception. https://doi.org/10.1016/j.contraception.2023.110343

Vancouver

Bharadwa S, Fulcher I, Fortin J, Pocius KD, Goldberg AB. hCG trends after mifepristone and misoprostol for undesired pregnancy of unknown location. Contraception. 2024. doi:10.1016/j.contraception.2023.110343

BibTeX
@article{Bharadwa2024,
  author = {Bharadwa, Sonya and Fulcher, Isabel and Fortin, Jennifer and Pocius, Katherine D and Goldberg, Alisa B},
  title = {hCG trends after mifepristone and misoprostol for undesired pregnancy of unknown location},
  journal = {Contraception},
  year = {2024},
  doi = {10.1016/j.contraception.2023.110343}
}
Kostenlos starten →